REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 85 filers reported holding REGULUS THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $0 | -100.0% | 2,000 | -77.5% | 0.00% | – |
Q2 2018 | $6,000 | 0.0% | 8,900 | 0.0% | 0.00% | – |
Q1 2018 | $6,000 | -33.3% | 8,900 | 0.0% | 0.00% | – |
Q4 2017 | $9,000 | -25.0% | 8,900 | 0.0% | 0.00% | – |
Q3 2017 | $12,000 | +33.3% | 8,900 | -5.3% | 0.00% | – |
Q2 2017 | $9,000 | -40.0% | 9,400 | 0.0% | 0.00% | – |
Q1 2017 | $15,000 | +150.0% | 9,400 | +276.0% | 0.00% | – |
Q4 2016 | $6,000 | -33.3% | 2,500 | 0.0% | 0.00% | – |
Q3 2016 | $9,000 | +50.0% | 2,500 | +25.0% | 0.00% | – |
Q2 2016 | $6,000 | -57.1% | 2,000 | 0.0% | 0.00% | – |
Q1 2016 | $14,000 | -17.6% | 2,000 | 0.0% | 0.00% | – |
Q4 2015 | $17,000 | +30.8% | 2,000 | 0.0% | 0.00% | – |
Q3 2015 | $13,000 | -40.9% | 2,000 | 0.0% | 0.00% | – |
Q2 2015 | $22,000 | -35.3% | 2,000 | 0.0% | 0.00% | -100.0% |
Q1 2015 | $34,000 | +6.2% | 2,000 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $32,000 | -5.9% | 2,000 | -60.0% | 0.00% | 0.0% |
Q3 2014 | $34,000 | -15.0% | 5,000 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $40,000 | -11.1% | 5,000 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $45,000 | – | 5,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 13,685,204 | $9,021,000 | 0.88% |
NEA Management Company, LLC | 10,989,910 | $7,244,000 | 0.34% |
Boxer Capital, LLC | 1,697,802 | $1,121,000 | 0.13% |
ASCEND CAPITAL, LLC | 1,068,361 | $705,000 | 0.03% |
Rhenman & Partners Asset Management AB | 492,878 | $325,000 | 0.03% |
South Dakota Investment Council | 1,683,601 | $1,110,000 | 0.02% |
WEDBUSH SECURITIES INC | 82,455 | $54,000 | 0.01% |
DRW Securities, LLC | 135,000 | $89,000 | 0.01% |
BOURGEON CAPITAL MANAGEMENT LLC | 13,304 | $9,000 | 0.01% |
Candriam S.C.A. | 500,000 | $330,000 | 0.01% |